WNT3A and familial pancreatic carcinoma: Another example is the molecules miR-15a and miR-16-1, whose dysregulation allows prostate and pancreatic cancers to develop by influencing the signaling pathways associated with CCND1 (cyclin D1), WNT3A and BCL2.